Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Subscribe to see Aimei Health Technology Co., Ltd’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aimei Health Technology Co., Ltd is a medical devices company headquartered in New York City, United States. It is publicly listed (AFJK) with a market capitalisation of $38M. Xcout tracks 8 named people at Aimei Health Technology Co., Ltd, including Junheng Xie (Chief Executive Officer, Secretary & Director).
2 more named people on record for Aimei Health Technology Co., Ltd, with roles, board committees and tenure — see the full roster →
A few of Aimei Health Technology Co., Ltd's closest competitors — see the full list of competitors and alternatives →
Aesthetic Medical International Holdings Group Ltd. engages in the provision of aesthetic medical services. It offers surgical and non-surgical treatments, cosmetic dentistry, and general healthcare services. The firm's treatments include eye surgery, rhinoplasty, breast augmentation, liposuction, laser, ultrasound, and ultraviolet light treatments. The company was founded by Zhou Peng Wu and Ding Wen Ting in 1997 and is headquartered in Shenzhen, China.
AcQumen Medical, Inc. is a health care corporation founded in June 2024 and headquartered in Minneapolis, Minnesota, United States.
Holobeam Technologies Inc. is a technology company headquartered in Bethpage, New York, that engages in corporate development and technological innovations.
Non-Invasive Monitoring Systems, Inc. (NIMU) currently lacks significant active business operations. Historically, its endeavors encompassed the research, development, manufacturing, promotion, and distribution of specialized therapeutic platforms. These devices employed non-invasive, motorized, whole-body periodic acceleration technology. The company was established in 1980 and maintains its headquarters in Miami, Florida.
Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.